Jenny Kobin | Head of IR |
George Lasezkay | President, CEO and Director |
Tom Ciulla | Chief Medical Officer and Chief Development Officer |
Charles Deignan | CFO |
Stacy Lee | Stifel |
Rohit Bhasin | Needham & Company |
Yi Chen | H.C. Wainwright |
William Wood | B. Riley |
Good day, and thank you for standing by. Welcome to the Clearside Biomedical Q2 2022 Financial Results and Corporate Update Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Jenny Kobin, Clearside Investor Relations. Please go ahead.